Status:
WITHDRAWN
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
Lead Sponsor:
Yale University
Conditions:
Hemangioma
Eligibility:
All Genders
Up to 1 years
Brief Summary
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whe...
Detailed Description
This study seeks to examine a potential relationship between CTCF genotype and hemangioma size and growth rate. In addition to the initial visit, patients will return to our clinic for evaluation at t...
Eligibility Criteria
Inclusion
- Hemangioma must appear within one month prior to enrollment
Exclusion
- Hemangioma appeared before one month prior to enrollment
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00974129
Start Date
September 1 2009
End Date
June 1 2012
Last Update
June 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Dermatology Associates
New Haven, Connecticut, United States, 06519